EMS
EMS
Explore linked clinical trials.14 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study to Evaluate DEP114 for the Treatment of Acute Exacerbation of Persistent Allergic Rhinitis in Children Aged 6 to Under 12 Years | Persistent Allergic Rhinitis | Not yet recruiting | Phase 3 | 2026-09-22 | NCT07835074 | |
| A Study to Investigate Efficacy and Safety of a TCA108 in Participants ≥18 Years With Uncontrolled Hypertension | cardiovascular disorder, hypertensive disorder, vascular disorder | Not yet recruiting | Phase 3 | 2026-07-10 | NCT07030101 | |
| Efficacy and Safety of CDE100 in the Treatment of Menstrual Cramp Pain Associated With Primary Dysmenorrhea | primary dysmenorrhea | Recruiting | Phase 3 | 2025-12-08 | NCT05640232 | |
| Efficacy and Safety of Piemonte Association in the Treatment of Type II Diabetes Mellitus | Nutritional and Metabolic Diseases, diabetes mellitus, endocrine system disorder, glucose metabolism disease, metabolic disease, type 2 diabetes mellitus | Recruiting | Phase 3 | 2025-12-08 | NCT05028140 | |
| Efficacy and Safety of Madalena Association in the Treatment of Type II Diabetes Mellitus | Nutritional and Metabolic Diseases, diabetes mellitus, endocrine system disorder, glucose metabolism disease, metabolic disease, type 2 diabetes mellitus | Recruiting | Phase 3 | 2025-12-08 | NCT04670666 | |
| Efficacy and Safety of Berlim 25/20 Association in the Treatment of Type II Diabetes Mellitus and Dyslipidemia. | Dyslipidemias, Lipid Metabolism Disorders, Nutritional and Metabolic Diseases, diabetes mellitus, endocrine system disorder, glucose metabolism disease, metabolic disease, type 2 diabetes mellitus | Recruiting | Phase 3 | 2025-12-08 | NCT04602754 | |
| Efficacy and Safety of Finlândia Hair Lotion Association on Androgenetic Alopecia | Pathological Conditions, Anatomical, Pathological Conditions, Signs and Symptoms, Skin and Connective Tissue Diseases, alopecia, androgenetic alopecia, disorder of pilosebaceous unit, hypotrichosis, skin disorder | Recruiting | Phase 3 | 2025-12-08 | NCT04594018 | |
| Efficacy and Safety of Praga Formulation in the Treatment of Neuropathic Pain | Neurologic Manifestations, Pain, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, nervous system disorder, neuralgia, neuromuscular disease, peripheral nervous system disorder | Recruiting | Phase 3 | 2025-03-14 | NCT04666714 | |
| Efficacy and Safety of DEP114 in the Treatment of Moderate to Severe Persistent Allergic Rhinitis in Children. | Hypersensitivity, Immediate, Respiratory Hypersensitivity, Rhinitis, Allergic, immune system disorder, nasal disorder, otorhinolaryngologic disease, respiratory system disorder, rhinitis | Not yet recruiting | Phase 3 | 2024-02-22 | NCT06272409 | |
| Efficacy and Safety of DEH113 in the Treatment of Menstrual Cramp Pain Associated With Primary Dysmenorrhea | primary dysmenorrhea | Not yet recruiting | Phase 3 | 2024-02-22 | NCT06268054 | |
| Efficacy and Safety of the DTT106 in the Treatment of Erectile Dysfunction Associated With Benign Prostatic Hyperplasia | Genital Diseases, Male Urogenital Diseases, Sexual Dysfunctions, Psychological, Urogenital Diseases, benign prostatic hyperplasia, erectile dysfunction, male reproductive system disorder, physiological sexual disorder, prostate disorder, psychiatric disorder | Not yet recruiting | Phase 3 | 2024-02-20 | NCT06264414 | |
| Efficacy and Safety of DIT112 in the Treatment of Moderate to Severe Pain After Dental Surgery for the Extraction of Impacted Third Molars | Neurologic Manifestations, Pain, Pathological Conditions, Signs and Symptoms, Signs and Symptoms | Not yet recruiting | Phase 3 | 2024-02-20 | NCT06237231 | |
| Efficacy and Safety of OMA102 in the Treatment of Female Pattern Hair Loss | Female Pattern Baldness, Pathological Conditions, Anatomical, Pathological Conditions, Signs and Symptoms, Skin and Connective Tissue Diseases, alopecia, disorder of pilosebaceous unit, hypotrichosis, skin disorder | Not yet recruiting | Phase 3 | 2024-02-16 | NCT05824065 | |
| Efficacy and Safety of LID104 in the Treatment of Type II Diabetes Mellitus | Nutritional and Metabolic Diseases, diabetes mellitus, endocrine system disorder, glucose metabolism disease, metabolic disease, type 2 diabetes mellitus | Not yet recruiting | Phase 3 | 2023-06-02 | NCT05886088 |